Stefansson K - Search Results

1

Immunoreactivity of LMO7 and other molecular markers as potential prognostic factors in oropharyngeal squamous cell carcinoma.

Israelsson P, Oda H, Öfverman C, Stefansson K, Lindquist D. Israelsson P, et al. Among authors: stefansson k. BMC Oral Health. 2024 Jun 25;24(1):729. doi: 10.1186/s12903-024-04510-4. BMC Oral Health. 2024. PMID: 38918827 Free PMC article.

2

LRIG1‑2 and LMO7 immunoreactivity in vulvar squamous cell carcinoma: Association with prognosis in relation to HPV‑DNA and p16INK4a status.

Stefansson K, Oda H, Öfverman C, Lundin E, Hedman H, Lindquist D. Stefansson K, et al. Oncol Rep. 2019 Jul;42(1):142-150. doi: 10.3892/or.2019.7138. Epub 2019 May 2. Oncol Rep. 2019. PMID: 31059071 Free PMC article.

3

Incidence of tonsillar cancer in northern Sweden: Impact of human papilloma virus.

Loizou C, Laurell G, Lindquist D, Öfverman C, Stefansson K, Nylander K, Olofsson K. Loizou C, et al. Among authors: stefansson k. Oncol Lett. 2015 Dec;10(6):3565-3572. doi: 10.3892/ol.2015.3775. Epub 2015 Oct 2. Oncol Lett. 2015. PMID: 26788170 Free PMC article.

4

ABO Blood Groups, RhD Factor and Their Association with Subclinical Atherosclerosis Assessed by Carotid Ultrasonography.

Mickelsson M, Ekblom K, Stefansson K, Liv P, Nyman E, Själander A, Näslund U, Hultdin J. Mickelsson M, et al. Among authors: stefansson k. J Clin Med. 2024 Feb 27;13(5):1333. doi: 10.3390/jcm13051333. J Clin Med. 2024. PMID: 38592146 Free PMC article.

5

A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo.

Henriksson ML, Francis MS, Peden A, Aili M, Stefansson K, Palmer R, Aitken A, Hallberg B. Henriksson ML, et al. Among authors: stefansson k. Eur J Biochem. 2002 Oct;269(20):4921-9. doi: 10.1046/j.1432-1033.2002.03191.x. Eur J Biochem. 2002. PMID: 12383250 Free article.

6

Smoking tobacco is associated with renal hyperfiltration.

Mickelsson M, Söderström E, Stefansson K, Andersson J, Söderberg S, Hultdin J. Mickelsson M, et al. Among authors: stefansson k. Scand J Clin Lab Invest. 2021 Dec;81(8):622-628. doi: 10.1080/00365513.2021.1989713. Epub 2021 Oct 20. Scand J Clin Lab Invest. 2021. PMID: 34669529 Free article.

7

Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases.

Stefansson K, Brattsand M, Roosterman D, Kempkes C, Bocheva G, Steinhoff M, Egelrud T. Stefansson K, et al. J Invest Dermatol. 2008 Jan;128(1):18-25. doi: 10.1038/sj.jid.5700965. Epub 2007 Jul 12. J Invest Dermatol. 2008. PMID: 17625593 Free article.

8

SPINK9: a selective, skin-specific Kazal-type serine protease inhibitor.

Brattsand M, Stefansson K, Hubiche T, Nilsson SK, Egelrud T. Brattsand M, et al. Among authors: stefansson k. J Invest Dermatol. 2009 Jul;129(7):1656-65. doi: 10.1038/jid.2008.448. Epub 2009 Feb 5. J Invest Dermatol. 2009. PMID: 19194479 Free article.

9

Stefansson K, Brattsand M, Ny A, Glas B, Egelrud T. Stefansson K, et al. Biol Chem. 2006 Jun;387(6):761-8. doi: 10.1515/BC.2006.095. Biol Chem. 2006. PMID: 16800737

10

A proteolytic cascade of kallikreins in the stratum corneum.

Brattsand M, Stefansson K, Lundh C, Haasum Y, Egelrud T. Brattsand M, et al. Among authors: stefansson k. J Invest Dermatol. 2005 Jan;124(1):198-203. doi: 10.1111/j.0022-202X.2004.23547.x. J Invest Dermatol. 2005. PMID: 15654974 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,070 results

Search Page

Filters